Description: There are a variety of regulatory changes that are being contemplated by the National Association of Insurance Commissioners (NAIC) that have the potential to materially impact actuarial, statutory reporting and disclosure requirements relating to reinsurance. This session will provide an introduction to these changes, explaining both the motivation as well as the potential impact these proposed changes may have on US ceding companies. The focus of the presentation will be primarily on changes affecting Asset Adequacy Testing and statutory risk transfer for combination Coinsurance / Yearly Renewable Term agreements. An update will be provided regarding industry responses to proposed changes and the potential timing for implementation of these new requirements.

Description: This session will focus on the topic of Bermuda Reinsurance: Operational Readiness for Changes. The presenters will examine the current state of the reinsurance industry in Bermuda and explore the operational strategies that companies must consider to stay ahead in a rapidly evolving market. The discussion will cover regulatory updates, and market shifts that are influencing the way reinsurance businesses operate. The presenters will also discuss operational capabilities and organizational structure to think about when designing a new entity.

Description: Prescription drug markets are undergoing rapid change - significant policy changes implemented through the Inflation Reduction Act, Congressional interest in long-awaited 340b reform, and a growing direct-to-consumer market have already changed the landscape significantly. The ongoing effects of these changes will continue to evolve for many years. Hear from leading prescription drug actuaries and pharmacy policy experts on what these changes mean for prescription drug markets and US healthcare more broadly.

Description: This session will discuss the existing and potential tax-favored opportunities for LTC insurance. It will use non-actuarial and actuarial tax experts to discuss the existing (and potentially non-controversial legislative possibilities) to deal with the impending societal issues associated with the baby boomers progressing towards a tidal wave of long-term care needs that will mostly be funded through a Medicaid system that will be unable to deal with it.

Description: How are regulation and innovation intertwined? How do we regulate AI/ML in the insurance industry? We will cover how regulators are striking the balance between protection of their constituents and supporting innovation. We will zoom into the case of Predictive Analytics and the regulatory attempt at avoiding undue discrimination. Let's discuss what this really means.

Description: This session will focus on how companies can use innovative approaches to managing their Long Term Care (LTC) blocks. It will focus on utilizing external data and machine learning to identify which strategies are likely to be more successful on particular blocks of business. The attendees will learn how they can better use data to improve future financial outcomes in their blocks.

Description: "Mental health in the workplace is not just a matter of individual well-being but also a critical driver of business performance. Failing to address workforce mental health increases risk exposure, and globally, poor mental health costs an estimated $1 trillion annually in lost productivity. With workplaces holding the power to significantly influence the mental health of employees—and by extension, their families and the broader community—there is an unparalleled opportunity for leaders to drive positive change. This facilitated discussion will explore how a strategic focus on mental health and well-being can unlock individual potential, reduce organizational risk, and enhance organizational performance. Attendees will learn how to assess their company's current workplace mental health programs, policies and practices, identify risk exposures, and make informed decisions that ensure a thriving, resilient workforce. By understanding and acting on these factors, leaders can pave the way for a successful future that builds on your corporate strength for future growth and innovation."

Description: Discover the multitude of risk transfer solutions and payment models available to health claims payers for cell & gene therapies in this Society of Actuaries webinar. Delving deeper into the topic, we will examine the different types of solutions, weigh their pros and cons, and explore the future prospects of this rapidly evolving area of the healthcare landscape. By expanding upon the pricing and risk exposure discussion from session two, this webinar provides valuable insights into the dynamic market for cell & gene therapies and its implications for actuaries.

Description: This session will cover emerging topics in the individual disability insurance (IDI) market. These topics include a discussion of disabled life mortality and recovery experience, an update from the SOA Individual Disability Experience Committee, and a preliminary glimpse at 2023 IDI sales experience. Attendees will gain an understanding of the latest trends in this complex market.

Description: In this session, we will review how the previous and current concerns of pharmacy actuaries will affect the forecasting and review of upcoming pipeline events. After this session, attendees will have a broader understanding of the implications of what is coming next in the pharmacy pipeline and how they can be thinking about it.